1 long-form article and 0 pre-market mentions covering $ILMN from AskMelon Research.
The bears spent a decade circling Exact Sciences with the same indictment: real revenue, real growth, and never a clean GAAP profit, all riding on a single stool-based colon-cancer test about to be fl…